Personality traits linked to toilet paper stockpiling

Following the fast spread of COVID-19 across Europe and North America in March 2020, many people began stockpiling commodities including toilet paper. Some companies reported an increase of up to 700 percent in toilet paper sales, despite calls from the government to refrain from “panic buying.”

In the new study, researchers surveyed 1,029 adults from 35 countries who were recruited through social media. Between 23 and 29 March 2020, participants completed the Brief HEXACO Inventory — which ranks six broad personality domains — and shared information on their demographics, perceived threat level of COVID-19, quarantine behaviors, and toilet paper consumption in recent weeks.

The most robust predictor of toilet paper stockpiling was the perceived threat posed by the pandemic; people who felt more threatened tended to stockpile more toilet paper. Around 20 percent of this effect was also based on the personality factor of emotionality — people who generally tend to worry a lot and feel anxious are most likely to feel threatened and stockpile toilet paper. The personality domain of conscientiousness — which includes traits of organization, diligence, perfectionism and prudence — was also a predictor of stockpiling.

Other observations were that older people stockpiled more toilet paper than younger people and that Americans stockpiled more than Europeans. The researchers pointed out that the variables studied explained only twelve percent of the variability in toilet paper stockpiling, which suggests that some psychological explanations and situational factors likely remain unaccounted for. “Subjective threat of COVID-19 seems to be an important trigger for toilet paper stockpiling. However, we are still far away from understanding this phenomenon comprehensively,” concludes Theo Toppe, co-author of the study.

Story Source:

Materials provided by Max Planck Institute for Evolutionary Anthropology. Note: Content may be edited for style and length.

Share Button

Elastomeric masks provide a more durable, less costly option for health care workers

A cost-effective strategy for health care systems to offset N95 mask shortages due to the Coronavirus Disease 2019 (COVID-19) pandemic is to switch to reusable elastomeric respirator masks, according to new study results. These long-lasting masks, often used in industry and construction, cost at least 10 times less per month than disinfecting and reusing N95 masks meant to be for single use, say authors of the study, published as an “article in press” on the Journal of the American College of Surgeons website in advance of print.

The study is one of the first to evaluate the cost-effectiveness of using elastomeric masks in a health care setting during the COVID-19 pandemic, said Sricharan Chalikonda, MD, MHA, FACS, lead study author and chief medical operations officer for Pittsburgh-based Allegheny Health Network (AHN), where the study took place.

Disposable N95 masks are the standard face covering when health care providers require high-level respiratory protection, but during the pandemic, providers experienced widespread supply chain shortages and price increases, Dr. Chalikonda said. He said hospitals need a long-term solution.

“We don’t know if there will be a shortage of N95s again. We don’t know how long the pandemic will last and how often there will be virus surges,” he said. “We believe now is the time to invest in an elastomeric mask program.”

Dr. Chalikonda said an immediate supply of elastomeric masks in a health care system’s stockpile of personal protective equipment is “game changing” given the advantages.

Benefits of elastomeric masks

Elastomeric masks are made of a tight-fitting, flexible, rubber-like material that can adjust to nearly all individuals’ faces and can withstand multiple cleanings, Dr. Chalikonda said. These devices, which resemble gas masks, use a replaceable filter. According to the Centers for Disease Control and Prevention (CDC), elastomeric masks offer health care workers equal or better protection from airborne infectious substances compared with N95 masks.

Like many hospitals during the COVID-19 crisis, AHN was disinfecting and reusing N95 masks for a limited number of uses. However, Dr. Chalikonda said, “Many caregivers felt the N95 masks didn’t fit quite as well after disinfection.”

At the end of March, AHN began a one-month trial of a half-facepiece elastomeric mask covering the nose and mouth. The mask holds a P100-rated cartridge filter, meaning it filters out almost 100 percent of airborne particles.

Until AHN could procure more elastomeric masks, the system began its program for P100 elastomeric mask “super-users”: those providers who have the most frequent contact with COVID-19 patients. At each of AHN’s nine hospitals in Pennsylvania and Western New York, the first providers to receive the new masks were respiratory therapists, anesthesia providers, and emergency department and intensive care unit (ICU) doctors and nurses. Initially, providers shared the reusable masks with workers on other shifts, and the masks underwent decontamination between shifts using vaporized hydrogen peroxide similar to the technique used to sterilize disposable N95 masks.

As more masks became available, workers kept their own mask and disinfected it themselves according to the manufacturer’s guidelines. Gradually AHN provided more staff with the new masks.

Among nearly 2,000 health care providers receiving fit testing for an elastomeric mask (as required for any mask to make sure no unfiltered air penetrates it), 94 percent could wear one, the investigators reported. The small number of workers without a proper fit received an alternate type of respirator mask.

After a month of use, no one wearing an elastomeric mask chose to return to an N95 mask, according to the authors. Regarding the elastomeric masks, Dr. Chalikonda said, “Our clinicians were very comfortable with the fit, knowing it was an equivalent if not superior amount of protection, and that these masks were intended to be reused.”

Furthermore, patients were receptive to their care providers wearing this type of respirator, he noted.

Cost savings

To determine if the elastomeric masks were cost-effective, the researchers performed a cost-benefit analysis over one month of mask disinfection and reuse comparing the new masks, with the filter replaced monthly, versus N95 masks at one hospital’s 18-bed intensive care unit (ICU). Although the elastomeric mask costs about $20 and the filter costs $10 compared with only $3 at that time for an N95 mask, the research team found the elastomeric masks were “conservatively” 10 times less expensive.

The cost savings, Dr. Chalikonda said, increases the longer they use the elastomeric masks, which often can last for years, and these masks can remain in storage for long periods, thus improving the planning and management of the medical supply stockpile for future outbreaks.

He explained the monthly cost is lower because they can disinfect elastomeric masks much more often, multiple caregivers can share the same mask, and, unlike N95s masks, they do not need to waste the mask after a failed fit test.

Another advantage of an elastomeric respirator program, according to Dr. Chalikonda, is it does not require any additional hospital resources to implement if the hospital already has an N95 mask reuse and resterilization program. The AHN elastomeric mask program presented fewer operational challenges than disinfecting N95 masks, he stated.

Other study authors are Hope Waltenbaugh, MSN, RN, CNOR, NE-BC; Sara Angelilli, MSN, RN, CNOR; Tiffany Dumont, DO; Curt Kvasager, MBA; Timothy Sauber, MD; Nino Servello, CRNA; Anil Singh, MD; and Rafael Diaz-Garcia, MD, FACS.

Share Button

COVID-19 may trigger new diabetes, experts warn

Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes.

A letter published today in the New England Journal of Medicine and signed by an international group of 17 leading diabetes experts involved in the CoviDiab Registry project, a collaborative international research initiative, announces the establishment of a Global Registry of new cases of diabetes in patients with COVID-19.

The Registry aims to understand the extent and the characteristics of the manifestations of diabetes in patients with COVID-19, and the best strategies for the treatment and monitoring of affected patients, during and after the pandemic.

Clinical observations so far show a bi-directional relationship between COVID-19 and diabetes. On the one hand, diabetes is associated with increased risk of COVID-19 severity and mortality. Between 20 and 30% of patients who died with COVID-19 have been reported to have diabetes. On the other hand, new-onset diabetes and atypical metabolic complications of pre-existing diabetes, including life-threatening ones, have been observed in people with COVID-19.

It is still unclear how SARS-Cov-2, the virus that causes COVID-19, impacts diabetes. Previous research has shown that ACE-2, the protein that binds to SARS-Cov-2 allowing the virus to enter human cells, is not only located in the lungs but also in organs and tissues involved in glucose metabolism such as the pancreas, the small intestine, the fat tissue, the liver and the kidney. Researchers hypothesise that by entering these tissues, the virus may cause multiple and complex dysfunctions of glucose metabolism. It has also been known for many years that virus infections can precipitate type 1 diabetes.

Francesco Rubino, Professor of Metabolic Surgery at King’s College London and co-lead investigator of the CoviDiab Registry project, said: “Diabetes is one of the most prevalent chronic diseases and we are now realizing the consequences of the inevitable clash between two pandemics. Given the short period of human contact with this new coronavirus, the exact mechanism by which the virus influences glucose metabolism is still unclear and we don’t know whether the acute manifestation of diabetes in these patients represent classic type 1, type 2 or possibly a new form of diabetes.”

Paul Zimmet, Professor of Diabetes at Monash University in Melbourne, Honorary President of the International Diabetes Federation and co-lead investigator in the CoviDiab Registry project said: “We don’t yet know the magnitude of the new onset diabetes in COVID-19 and if it will persist or resolve after the infection; and if so, whether or not or COVID-19 increases risk of future diabetes. By establishing this Global Registry, we are calling on the international medical community to rapidly share relevant clinical observations that can help answer these questions.”

Stephanie Amiel, Professor of Diabetes Research at King’s College London and a co-investigator of the CoviDiab Registry project said: “The registry focuses on routinely collected clinical data that will help us examine insulin secretory capacity, insulin resistance and autoimmune antibody status to understand how COVID-19 related diabetes develops, its natural history and best management. Studying COVID-19-related diabetes may uncover novel mechanisms of disease.”

Story Source:

Materials provided by King’s College London. Note: Content may be edited for style and length.

Share Button

Self-swabbing tests for COVID-19 accurate and safe, study reports

Test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus that were as accurate as samples collected by a health care worker, according to a small study by researchers at the Stanford University School of Medicine.

The study was published June 12 in the Journal of the American Medical Association.

The 30 study participants, who previously had tested positive for COVID-19, collected their own samples at a drive-through testing site after watching a short video animation and reading a one-page document instructing them how to perform the swab. The nasal swab for the study is more comfortable to use than the long nasopharyngeal swab currently used to collect samples from the back of the nasal cavity.

Allowing people who suspect they may have COVID-19 to collect their own sample has many advantages. Sample-collection kits could be widely distributed, allowing more people to be tested. Those using the kit wouldn’t have to travel to a testing site, negating the risk of transmission to health care workers and others with whom they interact in transit. Self-collection would also conserve supplies of personal protective equipment used by health care workers.

“There is an urgent need to increase our testing capacity to slow the overall spread of the virus,” said Yvonne Maldonado, MD, professor of pediatric infectious diseases and of health research and policy. “A sample collection procedure that can safely and easily be performed by the patient in their own car or at home could reduce the exposure of health care workers and also allow many more people to submit samples for testing.”

Maldonado is the senior author of the study, which was conducted in collaboration with Andra L. Blomkalns, MD, the Redlich Family Professor and professor and chair of emergency medicine, and Prasanthi Govindarajan, MD, associate professor of emergency medicine; senior research data analyst Jonathan Altamirano is the lead author.

Providing nasal swab instructions

The study participants had tested positive in March at Stanford Health Care for the virus that causes COVID-19. Maldonado and her team contacted each of them by phone at home and provided them with written instructions and a short video about how to collect a nasal swab.

They were asked to return to Stanford Health Care for drive-through testing. At that visit, they collected their own specimen by applying a nasal swab to both nostrils. Then, a physician collected two additional samples using a nasal swab and a swab applied to the back of the throat and the tonsils. All three samples were tested for the presence of the virus at the Stanford Clinical Virology Laboratory.

Of the 30 participants, 29 received identical results — either positive or negative for the presence of the virus — for the three samples. Eleven of the participants were positive, and 18 were negative. One person’s self-collected swab at the drive-through site revealed the presence of the virus, whereas the two swabs collected by the physician tested negative.

The researchers were also interested in learning how long an infected person would test positive for the virus after they first experienced symptoms.

Twenty-three participants reported that they first experienced symptoms between four and 37 days prior to returning for the drive-through test. (The timing of symptom onset was unavailable for seven of the participants.) Of the 12 people who returned within two weeks after symptoms began, seven tested positive; of the 11 people who returned for testing more than two weeks after symptom onset, only two tested positive.

“It is critical for us to understand how long an infected person may remain infectious and what the pattern of transmission might be within their household,” Maldonado said. “This information would help public health workers craft guidelines as to how long a person with COVID-19 should remain quarantined and when it is likely to be safe to interact again with family members and co-workers. Understanding the timeline of viral shedding will be particularly important for previously infected health care workers who are needed to care for other COVID-19 patients.”

Other Stanford co-authors of the study are pediatric fellow Lauren Kushner, MD; pathology fellow Bryan Stevens, MD; and Benjamin Pinsky, MD, PhD, associate professor of pathology and of medicine.

Story Source:

Materials provided by Stanford Medicine. Original written by Krista Conger. Note: Content may be edited for style and length.

Share Button

As rare animals disappear, scientist faces ‘ecological grief’

Five years before the novel coronavirus ran rampant around the world, saiga antelopes from the steppes of Eurasia experienced their own epidemic.

Millions of these grazing animals — easily recognizable by their oversized snouts — once migrated across what is today Kazakhstan, Mongolia, Georgia and more.

But then, over the span of three weeks in 2015, nearly 200,000, or two-thirds of their existing population, sickened and died from a bacterial infection. Today, the a little more than 100,000 saiga are hanging onto survival in a few pockets of Eurasia.

The decline, and uncertain fate, of the saiga is a story that resonates with Joanna Lambert. She’s a conservation biologist at the University of Colorado Boulder and a coauthor of a paper published this week in the journal Frontiers in Ecology and Evolution. The study explores the current state of ungulates, or hoofed animals like the saiga, in the western U.S. and around the world.

Lambert, who has studied ecological communities in both North America and Equatorial Africa, explained that many of these creatures aren’t well-known outside of their home regions. But when these animals disappear, entire ecosystems can reshuffle, occasionally beyond recognition.

“We’re losing these animals without people ever knowing they were there in the first place,” said Lambert, a professor in the Program of Environmental Studies at CU Boulder.

For the researcher, the study’s publication marks an opportunity to reflect on how she stays hopeful even amid tremendous losses — and how to talk about the natural world during a period of unprecedented social upheaval.

“I tell my students, ‘I have to give you the facts. This is the world you’re growing up in, but don’t let that paralyze you,'” Lambert said.

Unsung species

The new research was led by Joel Berger of Colorado State University and also included scientists from Bhutan, Argentina and Chile.

The team decided to look at ungulates because — with a few exceptions like rhinos and elephants — they don’t usually pop up in brochures for conservation organizations. But, Lambart said, they’re still in trouble: Huemel, for example, once roamed across the Patagonia region of South America. Today, a little more than 1,000 of these fluffy deer still live in the wild. The tamaraw, a pint-sized buffalo from the Philippines, is down to just a few hundred individuals.

“The whole world knows the stories of pandas and mountain gorillas, but there are untold numbers of unsung species that come and go without the world’s attention,” she said.

Their cases also show just how complicated conservation can be.

Lambert has spent years trekking the grasslands and forests of Yellowstone National Park to study wildlife. After federal officials killed all the park’s wolves in the 1940s, elk herds there began to multiply — big time. Head counts for these herbivores surged from a few thousand individuals to tens of thousands, and they devoured once-abundant plants like cottonwood and willow trees.

“When you pull one species out of its community, or if you add a new one in, the entire assembly changes,” Lambert said. “That has been the history of what humans have done on the planet.”

When the park brought wolves back in the 1990s, and elk numbers dropped back down, something unexpected happened: beavers, which had also disappeared from Yellowstone, began reappearing, too. The furry swimmers, it turns out, depend on those same tree species to build their dams.

“In many cases, we don’t know what rules these ecosystems followed in the past,” she said. “Even when we do know, it doesn’t matter because we now have this added element of human tinkering.”

Ecological grief

Lambert has also struggled to keep going as a conservation biologist as the wilds around her field sites in Africa and North America dwindled, then vanished entirely.

“As I returned each year from the field, it was taking me longer and longer to recover from a sort of existential depression,” she said. “I realized that I have been profoundly impacted by the losses I’ve seen.”

Many of Lambert’s students feel similarly hopeless, a phenomenon that psychologists call “ecological grief.” She tells them to focus on the success stories, however rare they are. Protected areas like Yellowstone have saved countless animals from extinction and have given others like wolves new chances at survival. Lambert is also providing scientific guidance around proposals to return wolves to Colorado.

And there are still a lot of animals out there — including the few remaining herds of big-nosed saiga.

“We need to fight like hell to keep all that,” she said.

Share Button

Up to 45 percent of SARS-CoV-2 infections may be asymptomatic

An extraordinary percentage of people infected by the virus behind the ongoing deadly COVID-19 pandemic never show symptoms of the disease, according to the results of a Scripps Research analysis of public datasets on asymptomatic infections.

The findings, published in Annals of Internal Medicine, suggest that asymptomatic infections may account for as much as 45 percent of all COVID-19 cases, playing a significant role in the early and ongoing spread of COVID-19. The report highlights the need for expansive testing and contact tracing to mitigate the pandemic.

“The silent spread of the virus makes it all the more challenging to control,” says Eric Topol, MD, founder and director of the Scripps Research Translational Institute and professor of Molecular Medicine at Scripps Research. “Our review really highlights the importance of testing. It’s clear that with such a high asymptomatic rate, we need to cast a very wide net, otherwise the virus will continue to evade us.”

Together with behavioral scientist Daniel Oran, Topol collected information from testing studies on 16 diverse cohorts from around the world. These datasets — gathered via keyword searches of PubMed, bioRxiv and medRxiv, as well as Google searches of relevant news reports — included data on nursing home residents, cruise ship passengers, prison inmates and various other groups.

“What virtually all of them had in common was that a very large proportion of infected individuals had no symptoms,” says Oran. “Among more than 3,000 prison inmates in four states who tested positive for the coronavirus, the figure was astronomical: 96 percent asymptomatic.”

The review further suggests that asymptomatic individuals are able to transmit the virus for an extended period of time, perhaps longer than 14 days. The viral loads are very similar in people with or without symptoms, but it remains unclear whether their infectiousness is of the same magnitude. To resolve that issue, we’ll need large-scale studies that include sufficient numbers of asymptomatic people.

The authors also conclude that the absence of symptoms may not imply an absence of harm. CT scans conducted on 54 percent of 76 asymptomatic individuals on the Diamond Princess cruise ship, appear to show significant subclinical lung abnormalities raising the possibility of SARS-CoV-2 infection impacting lung function that might not be immediately apparent. The scientists say further research is needed to confirm the potential significance of this finding.

The authors also acknowledge that the lack of longitudinal data makes distinguishing between asymptomatic and presymptomatic individuals difficult. An asymptomatic individual is someone who is infected with SARS-CoV-2, but never develops symptoms of COVID-19, while a presymptomatic person is similarly infected, but will eventually develop symptoms. Longitudinal testing, which refers to repeated testing of individuals over time, would help differentiate between the two.

“Our estimate of 40 to 45 percent asymptomatic means that, if you’re unlucky enough to get infected, the probability is almost a flip of a coin on whether you’re going to have symptoms. So to protect others, we think that wearing a mask makes a lot of sense,” Oran concludes.

Story Source:

Materials provided by Scripps Research Institute. Note: Content may be edited for style and length.

Share Button

Coronavirus: Deprived areas hit twice as hard

London was overwhelmingly the hardest-hit area in the country, says the Office for National Statistics.

Share Button

Health24.com | Is it a heart attack or just bloating?

  • Sophisticated medical equipment can sometimes give false readings
  • A man who was sedated and on a ventilator in the ICU showed signs of a heart attack when he was merely bloated
  • Non-heart-related possible causes of such false readings include pancreatitis, pneumonia and intracranial bleeding

_____________________________________________________________________________________________________________________

Severe bloating can put pressure on the heart and trigger heart monitor readings that can be mistaken for a heart attack, a new case report shows.

It involved a previously healthy 41-year-old man who was seen by doctors at the University of Southern California in Los Angeles, after three weeks of lower extremity swelling, fatigue and shortness of breath.

He was taken to the intensive care unit and later diagnosed with metastatic Hodgkin lymphoma.

While under sedation on a ventilator in the ICU, the man’s heart monitor suddenly showed the onset of ST-segment elevations – often an indicator of a heart attack.

Preventing unnecessary treatment

But when pressure was placed on the man’s upper abdomen to assess the severe bloating, the heart monitor suddenly stopped showing ST-segment elevations, according to the report in the 15 April issue of the journal JACC: Case Reports.

After a nasogastric tube was inserted to relieve the man’s bloating, an electrocardiogram (ECG) confirmed the halt of ST-segment elevations, and the man did not have any further signs of heart trouble.

“It is important to be aware that, while rare, acute gastrointestinal distention can cause ST-segment changes on an ECG. Clinicians must distinguish these cases from true heart attacks to prevent unnecessary treatment and invasive procedures whenever possible,” senior author and cardiologist Dr Enrique Ostrzega said in a journal news release.

Some non-heart-related causes of ST-segment elevation include pancreatitis, community-acquired pneumonia and intracranial bleeding.

“Careful clinical examination and setting up the correct differential diagnosis is the cornerstone of the treatment of every patient. Here – starting from an important observation – [the authors] treated the patient without needing interventional procedures,” journal editor-in-chief Dr Julia Grapsa said in the release.

Image credit: iStock

Share Button

Health24.com | Tips for staying safe – if you really need a face-to-face doctor’s visit

  • At level 3 you can visit healthcare professionals like doctors and dentists
  • There are a few extra steps you can take to keep yourself safe when going for an appointment
  • Remember, do not keep your appointment if you’re experiencing Covid-19 symptoms

Coronavirus is dominating conversations about health – but it doesn’t mean that all other health concerns have magically disappeared. 

We still have to see doctors, dentists, psychiatrists and other healthcare professionals for various other ailments and illnesses. With enforced physical distancing rules, telemedicine is becoming more popular, helping people access healthcare without putting themselves and their healthcare professionals at risk. 

This involves non-emergency appointments taking place virtually, talking to a healthcare professional about your ailments online or over the telephone, getting a diagnosis and even getting prescriptions that can be emailed.

READ: ‘Telemedicine’ stepping up amid coronavirus spread

However, there are still times you have to see a professional face-to-face to assess you better and perform physical actions. At present, making that appointment might seem somewhat daunting with the spectre of Covid-19 hanging over your head. 

Screening questions

Don’t make the appointment if you have coronavirus symptoms. The first and most important thing to remember is to not visit any healthcare professional if you are showing symptoms of the coronavirus. 

This includes a fever, a new and persistent cough, shortness of breath and/or a loss of smell and taste. 

If you have any of these symptoms, self-isolate and consult your doctor via telephone or virtual appointment to determine whether you need to get a test. 

Most ask screening questions before letting make an appointment. Before your appointment is confirmed, most practices will ask you questions regarding Covid-19-related symptoms, contact with anyone who has tested positive, your age, and if you’re in lockdown with a vulnerable person. 

This will give you some sense of comfort in that they are aiming to ensure your safety as well as their own. You can also ask them questions about the precautions they’re taking to give you peace of mind.

Take hand sanitiser with you

While hand sanitiser will be available at any health professional’s practice, having your own will help you sanitise every time you touch a surface. 

Also, wash your hands thoroughly before and after an appointment – help those looking after your health to remain healthy themselves.

ALSO READ: Touching your face is a coronavirus danger: tips to help you stop

Practising physical distancing in the reception room

The South African Dental Association recommends that patients try to arrive at their appointment exactly on time to minimise waiting in the reception room area. If you arrive early, another idea is to stay in your car until the time of your appointment. 

Most practices would have removed the customary reading material, but if they didn’t, avoid browsing or touching any surfaces in the reception area. 

Also, maintain physical distancing practices by sitting far apart from other patients. 

Wear your cloth mask during the appointment

Unless you’re visiting the dentist, or your mouth needs to be examined, keep your cloth mask on throughout the whole procedure. 

The healthcare professional will also keep their mask on throughout the appointment. 

Don’t annoy the healthcare professional by wearing surgical masks or N95 respirators – these are in short supply, and medical professionals need them. 

SEE: If you’re making a DIY face mask, these are the best materials to use according to science

What about visiting the dentist?

According to Health24, a patient is far less likely to pick up coronavirus from a dentist than the other way around. They and their assistants have to wear masks and eye coverings, and have been taking effective safety precautions since even before the outbreak. 

In your case, only remove your mask when instructed to and never in the reception area. 

Image credit:

Share Button

Coronavirus: Positive tests continue to fall in England, says ONS

One in 1,700 people are thought to be infected, based on 20,000 tests in households.

Share Button